Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

What to Expect From DexCom's Q4 2024 Earnings Report

Valued at $33 billion by market cap, DexCom, Inc. (DXCM) is a global leader in continuous glucose monitoring (CGM) technology. Headquartered in San Diego, California, the company specializes in innovative solutions that empower individuals with diabetes to better manage their health through real-time glucose tracking. The company is set to release its Q4 earnings on Thursday, Feb. 13.

Ahead of this event, analysts project the medical device company to report a profit of $0.51 per share, up 2% from $0.50 per share in the year-ago quarter. The company has consistently surpassed Wall Street's bottom-line estimates in the last four quarterly reports. In the most recent quarter, DexCom posted an EPS of $0.45, surpassing the consensus estimate by 4.7%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.